Featured articles from the journal CHEST®, August 2023
Glenview, Ill | 2023년 8월 16일
Published monthly, the journal CHESTopens in new tab/window® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.
The August issueopens in new tab/window of the CHEST journal contains 47 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resourcesopens in new tab/window, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.
“With recommendations for mouthpiece ventilation, transition to home mechanical ventilation, salivary secretion management and airway clearance therapies, the August issue contains new clinical practice guideline, ‘Respiratory Management of Patients With Neuromuscular Weaknessopens in new tab/window,’” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “Also featured in the August issue is the multisociety evidence review, ‘Effect of Race and Ethnicity on Pulmonary Function Testing Interpretationopens in new tab/window.’”
Additional highlights from the latest issue of the journal CHEST include:
Diffuse Lung Disease Original research, “Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosisopens in new tab/window,” shows that, among 14,792 veterans with idiopathic pulmonary fibrosis, 17% received antifibrotics, and there were significant disparities in adoption associated with sex, race, and residence. View the visual abstract for this research.opens in new tab/window

What Are the Real-World Antifibrotic Utilization Rates and Factors Associated With Uptake in Idiopathic Pulmonary Fibrosis? (Credit: Bhavika Kaul, MD, et al. CHEST, August 2023, https://doi.org/10.1016/j.chest.2023.02.027opens in new tab/window).
Pulmonary Vascular In a retrospective observational study, “Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients With Precapillary Pulmonary Hypertensionopens in new tab/window,” lack of respiratory variation in right atrial pressure was associated with lower cardiac index. View the visual abstract for this research.opens in new tab/window
Sleep A large cohort study, “Polysomnographic Assessment of Sleep Disturbances in Cancer Developmentopens in new tab/window,” confirms the importance of polysomnographic phenotypes and highlights the role that periodic limb movements of sleep and oxygenation desaturation may play in cancer. View the visual abstract for this researchopens in new tab/window
---
Notes for editors
To view the entire August issue of CHEST journal (volume 164, issue 2), published by Elsevier, visit journal.chestnet.orgopens in new tab/window and follow @journal_CHESTopens in new tab/window on social media for the latest journal news.
Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, Senior Specialist, Communications and Public Relations, American College of Chest Physicians (CHEST), at [email protected]opens in new tab/window.
About the journal CHEST®
The journal CHESTopens in new tab/window, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.orgopens in new tab/window.
About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.opens in new tab/window
엘스비어 소개
엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.
엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.
Media Contact
LD
Laura DiMasi
PR and Communications Specialist
American College of Chest Physicians (CHEST)
Laura DiMasi 이메일